Literature DB >> 870272

Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.

D S Davies, A M Wing, J L Reid, D M Neill, P Tippett, C T Dollery.   

Abstract

The kinetics of the disposition of intravenous and oral clonidine in five normotensive subjects have been determined. It is proposed that a two-compartment model adequately describes the disposition of the drug. The drug is rapidly distributed (t1/2alpha = 10.8 +/- 4.7 min) but slowly elimainated (t1/2beta = 8.5 +/- 0.9 hr). The bioavailability of oral clonidine in the tablets tested averaged 75.2% and 40 to 50% of the bioavailable dose is excreted unchanged in urine. Renal clearance of the drug showed considerable intersubject variation (1.82 +/- 0.34 ml/min/kg) and exceed the calculated glomerular filtration rate in some subjects. Oral and intravenous clonidine induced significant falls in blood pressure (greater than 20/15 mm Hg) in our normotensive subjects and consistently caused marked sedation and dryness of the mouth. Sedation and salivary flow correlated with plasma clonidine concentration over the range 0 to 4 ng/ml. Falls in blood pressure were related to plasma concentration to 1.5 to 2 ng/ml but at higher concentrations the hypotensive effect was attenuated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870272     DOI: 10.1002/cpt1977215593

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  50 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

2.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Role of monoamine pathways in attention and effort: effects of clonidine and methylphenidate in normal adult humans.

Authors:  C R Clark; G M Geffen; L B Geffen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

5.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  Pharmacokinetic and concentration-effect studies with intravenous metoclopramide.

Authors:  D N Bateman; C Kahn; K Mashiter; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

7.  Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.

Authors:  L M Wing; J L Reid; D S Davies; E A Neill; P Tippett; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

8.  Use of oral clonidine for sedation in ventilated paediatric intensive care patients.

Authors:  Sara Arenas-López; Shelley Riphagen; Shane M Tibby; Andrew Durward; Steve Tomlin; Graham Davies; Ian A Murdoch
Journal:  Intensive Care Med       Date:  2004-06-10       Impact factor: 17.440

9.  Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.

Authors:  D Arndts; K Arndts
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Does preoperative oral clonidine inhibit salivary secretion during general anesthesia?

Authors:  R Numazawa; T Mayumi; O Kemmotsu
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.